Background:Because Acinetobacter baumannii bacteremia is a global problem, we were motivated to characterize this disease in Taiwan. Patients and Methods: We analyzed findings in 95 patients with documented A. baumannii bacteremia between January 1, 1998 and December 31, 2000 (47 men, 48 women; mean age 58.8 years). Results: The mean length of stay in the hospital was 44.0 days. Clinically, 76 patients had fever and 35 patients developed shock. Fifty patients had respiratory tract infections; 24, urinary tract infections; 11, intra-abdominal infections; three, CNS infections; and two, catheter-related infections. Five patients had primary bacteremia. Empirical antibiotic therapy was initiated at the onset of the clinical signs of infection. Antimicrobial susceptibility test results were variable. 47 patients died and 48 survived; the mortality rate for A. baumannii bacteremia was 45.3% (43/95). Conclusion: Physicians should pay attention to this infection because the early identification of high-risk patients could facilitate prophylaxis and potentially reduce associated problems.
Ultradünne (5–7 nm Durchmesser) und ultralange (Seitenverhältnis >104) PtPdTe‐Nanodrähte (NWs) wurden mit einer einfachen Methode synthetisiert, die Te‐NWs als Opfertemplat und Reduktionsmittel nutzt. Die Justierung des molaren Verhältnisses von Pt‐ und Pd‐Vorstufen führte zu PtPdTe‐NWs mit verschiedenen Zusammensetzungen, deren Elektroaktivitäten in der Methanoloxidation besser waren als die kommerzieller Pt/C‐Katalysatoren.
Purpose
Klebsiella pneumoniae
is an important causative pathogen of nosocomial infections, resulting in poor prognosis owing to its hypervirulence and antibiotic resistance. A simplified quicker version of the Pitt bacteremia score (PBS) (qPitt) for acute illness severity measurement was developed recently. The goal of this study was to explore the prognostic value of qPitt in patients with
K. pneumoniae
infection.
Patients and Methods
Demographic information and management strategies were retrospectively collected from the records of all adult patients who visited the emergency department between January 1, 2021, and December 31, 2021, with culture-positive
K. pneumoniae
. The qPitt score was calculated based on: temperature <36°C, systolic blood pressure ≤90 mmHg or vasopressor administration, respiratory rate ≥25 times/min or need of mechanical ventilation, altered mental status, and cardiac arrest event. The 30-day mortality prediction abilities of the qPitt were compared with the PBS, the sequential organ failure assessment (SOFA), and the quick sequential organ failure assessment (qSOFA) using receiver operating characteristic curves.
Results
Data from 867 patients (57.8% men) with a mean age of 66.9 were compiled. The 30-day mortality rate of the enrolled patients was 13.4%, and the area under the curve (AUC) of the scoring systems were as follows: SOFA, 0.91 (95% confidence interval [CI]=0.89–0.93), qPitt, 0.87 (95% CI=0.84–0.89), PBS, 0.87 (95% CI=0.85–0.89), and qSOFA, 0.73 (95% CI=0.70–0.76). The AUC of qPitt was significantly higher than that of qSOFA (
p
<0.01) and similar to that of PBS (
p
=0.65).The qPitt also demonstrated excellent mortality discrimination ability in non-bacteremic patients, AUC= 0.85 (95% CI=0.82–0.88).
Conclusion
The qPitt revealed excellent 30-day mortality prediction ability and also predicted mortality in non-bacteremic patients with
K. pneumoniae
infection. Clinicians can use this simplified scoring system to stratify patients earlier and initiate prompt treatment in high-risk patients.
Education for infection control programs, hand hygiene campaigns, and antibiotics control programs may decrease the incidence density of AB and HAI, and may help control CRA complex infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.